Corrigendum

The Research Article by Kimberly A Fisher et al., ‘COVID-19 clinical trials: who is likely to participate and why?’, which appeared in the August 2024 issue of the Journal of Comparative Effectiveness Research 13(8), e230181 (2024), was published with an error in the financial disclosure information.

The disclosure appeared as:

This work was supported by a grant from the NIH (grant no.: 1OT2HL156812-01). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

The correct disclosure is:

This research was, in part, funded by the National Institutes of Health (NIH) Agreement OT2HL158287. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the NIH. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

This has now been corrected.

The authors and editors of the Journal of Comparative Effectiveness Research would like to apologize for any inconvenience or confusion this may have caused our readers.